Product information

Current status:

Cancelled Pre Market

Current status date:

2018-08-01

Original market date: ^{See footnote 1}

Product name:

NEOSTIGMINE METHYLSULFATE INJECTION SDZ

DIN:

02385201 Electronic product monograph is not available

Company:

SANDOZ CANADA INCORPORATED
4600 Rue Armand-Frappier
Saint-Hubert
Quebec
Canada J3Z 1G5

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular ,  Intravenous ,  Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

PRESCRIPTION

American Hospital Formulary Service (AHFS): ^{See footnote 3}

12:04.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N07AA01 NEOSTIGMINE

Active ingredient group (AIG) number:^{See footnote5}

0102263002